End-of-day quote
Taipei Exchange
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
78.2
TWD
|
-.--%
|
|
+0.90%
|
-9.80%
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
1,681
|
1,241
|
2,190
|
1,976
|
Enterprise Value (EV)
1 |
1,681
|
1,241
|
2,190
|
1,976
|
P/E ratio
|
18.6
x
|
11
x
|
21.2
x
|
14.5
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.54
x
|
-
|
2.66
x
|
2.06
x
|
EV / Revenue
|
2.54
x
|
-
|
2.66
x
|
2.06
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
14.6
x
|
30.9
x
|
FCF Yield
|
-
|
-
|
6.83%
|
3.24%
|
Price to Book
|
-
|
-
|
2.56
x
|
-
|
Nbr of stocks (in thousands)
|
22,491
|
25,057
|
25,264
|
25,264
|
Reference price
2 |
74.76
|
49.52
|
86.70
|
78.20
|
Announcement Date
|
29/03/20
|
24/02/23
|
01/03/24
|
-
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
661.1
|
-
|
824
|
961
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
114.1
|
-
|
117.7
|
170
|
Operating Margin
|
17.25%
|
-
|
14.28%
|
17.69%
|
Earnings before Tax (EBT)
1 |
111.7
|
-
|
119.7
|
170
|
Net income
1 |
91.08
|
115
|
103.2
|
138
|
Net margin
|
13.78%
|
-
|
12.53%
|
14.36%
|
EPS
2 |
4.019
|
4.514
|
4.090
|
5.410
|
Free Cash Flow
1 |
-
|
-
|
149.6
|
64
|
FCF margin
|
-
|
-
|
18.16%
|
6.66%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
145%
|
46.38%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/20
|
24/02/23
|
01/03/24
|
-
|
Fiscal Period: December |
2019 S2
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
327.7
|
-
|
220
|
189.4
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
52.8
|
-
|
24.24
|
31.17
|
Operating Margin
|
16.11%
|
-
|
11.02%
|
16.45%
|
Earnings before Tax (EBT)
1 |
47.99
|
-
|
29.14
|
25.97
|
Net income
1 |
42.56
|
34.47
|
23.31
|
18.39
|
Net margin
|
12.99%
|
-
|
10.6%
|
9.71%
|
EPS
2 |
1.876
|
1.380
|
0.9300
|
0.7100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/20
|
14/08/23
|
14/11/23
|
01/03/24
|
Fiscal Period: December |
2019
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
150
|
64
|
ROE (net income / shareholders' equity)
|
-
|
-
|
12.7%
|
15.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
9.89%
|
12.2%
|
Assets
1 |
-
|
-
|
1,044
|
1,131
|
Book Value Per Share
|
-
|
-
|
33.90
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
4.37
|
50
|
Capex / Sales
|
-
|
-
|
0.53%
|
5.2%
|
Announcement Date
|
29/03/20
|
24/02/23
|
01/03/24
|
-
|
Last Close Price
78.2
TWD Average target price
92
TWD Spread / Average Target +17.65% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.80% | 60.58M | | -8.59% | 8.9B | | +26.36% | 1.9B | | -2.74% | 1.41B | | -7.86% | 1.19B | | -16.38% | 878M | | +1.00% | 470M | | +3.05% | 435M | | -47.25% | 377M | | -22.11% | 345M |
Medical Equipment Wholesale
|